Agenda – Xconomy

Wednesday, December 5

5:00 – 6:00	Registration & Networking
6:00 – 6:05	Welcome and Opening Remarks Bob Buderi, Xconomy
6:10 – 6:40	The RDMD Story Sparked from a Silicon Valley hackathon, RDMD is building repositories of patient health data to encourage new drugs for rare diseases. Introduction: Tiffany Reiter, Fish & Richardson Nancy Yu, RDMD Onno Faber, RDMD Tristen Moors, Modis Therapeutics
6:45 – 7:15	The Cortexyme Story With more than $90 million in funding, drug developer Cortexyme thinks bacteria in the brain could be at play with Alzheimer’s and other neurodegenerative diseases. Casey Lynch, Cortexyme David Dolby, Dolby Family Ventures
7:15 – 7:45	The Allogene Therapeutics Story Allogene is developing what it hopes will be more affordable cancer cell therapies for a wider range of cancer patients, made from donor cells rather than a patient’s own T cells. David Chang, Allogene Therapeutics Alison Moore, Allogene Therapeutics Wendell Lim, UCSF Center for Systems & Synthetic Biology Alex Lash, Xconomy (moderator)
7:45 – 8:45	Networking Reception

Please note that this schedule is subject to change.